Black Rock Inc. Avidity Biosciences, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,622,513 shares of RNA stock, worth $276 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,622,513
Previous 6,165,991
39.84%
Holding current value
$276 Million
Previous $157 Million
123.84%
% of portfolio
0.01%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RNA
# of Institutions
256Shares Held
108MCall Options Held
517KPut Options Held
717K-
Price T Rowe Associates Inc Baltimore, MD11MShares$353 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.43MShares$302 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.11MShares$259 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY7.93MShares$254 Million3.76% of portfolio
-
Avoro Capital Advisors LLC New York, NY7.5MShares$240 Million3.18% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.67B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...